Feasibility of continuous, catheter-directed thrombolysis using low-dose urokinase in combination with low molecular-weight heparin for acute iliofemoral venous thrombosis in patients at risk of bleeding
Authors:
Open Access
- 4 January 2017
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 13 (2) , 751-758
Abstract
The present study aimed to examine the feasibility of catheter-directed thrombolysis (CDT) using continuous infusion of low-dose urokinase in combination with low molecular weight heparin (LMWH) for acute iliofemoral venous thrombosis. This retrospective analysis included patients with symptomatic acute iliofemoral venous thrombosis who received CDT using continuous infusion of low-dose urokinase in combination with LMWH within the past four years. Urokinase was administered at 1×104 U/h and 2×104 U/h in patients at high-risk and low-risk of bleeding, respectively. Measurements included urokinase dosage, duration, clinical outcomes and CDT-related complications. A total of 46 patients were included (high-risk, n=17; low-risk, n=29). In the high-risk patients, 64.7% experienced dissolution of ≥50% thrombi after a median CDT duration of 8 days (range, 6–10 days) and median total urokinase dose of 1.92×106 units (range, 1.44–2.4×106 units). In the low-risk patients, 82.8% achieved dissolution of ≥50% thrombi after a median CDT duration of 7 days (range, 4–10 days) and a median total urokinase dose of 3.36×106 units (range, 1.92–4.80×106 units). Remission of clinical symptoms after CDT was achieved in 15 (88.2%) and 28 (96.6%) cases in high-risk and low-risk patients, respectively. No treatment-associated pulmonary embolism or major bleeding was observed. Three (6.5%) subjects (high-risk, n=1; low-risk, n=2) experienced minor bleeding. In conclusion, continuous infusion of low-dose urokinase via CDT in combination with LMWH is effective and safe for acute iliofemoral venous thrombosis in patients with one or more risk factor for bleeding.Keywords
This publication has 27 references indexed in Scilit:
- Quality Improvement Guidelines for the Treatment of Lower-Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus RemovalJournal of Vascular and Interventional Radiology, 2014
- Catheter-directed thrombolysis of proximal lower extremity deep vein thrombosis: A prospective trial with venographic and clinical follow-upEuropean Journal of Radiology, 2012
- Pulmonary embolism and deep vein thrombosisThe Lancet, 2012
- Epidemiology, risk factors and sequelae of venous thromboembolismPhlebology: The Journal of Venous Disease, 2012
- Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patientsJournal of Vascular Surgery, 2008
- Adjunctive Percutaneous Mechanical Thrombectomy for Lower-extremity Deep Vein Thrombosis: Clinical and Economic OutcomesJournal of Vascular and Interventional Radiology, 2006
- Stents in Common Iliac Vein Obstruction with Acute Ipsilateral Deep Venous Thrombosis: Early and Late ResultsJournal of Vascular and Interventional Radiology, 2005
- Comparison of Urokinase, Alteplase, and Reteplase for Catheter-directed Thrombolysis of Deep Venous ThrombosisJournal of Vascular and Interventional Radiology, 2004
- Catheter-directed Thrombolysis for Lower Extremity Deep Venous Thrombosis: Report of a National Multicenter RegistryRadiology, 1999
- Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis.Radiology, 1994